Successful Anti-SARS-CoV-2 Spike Protein Antibody Response to Vaccination in Deficiency
Background Novel messenger RNA vaccines against severe acute respiratory syndrome coronavirus (SARS-CoV-2) have been vital in resolving the coronavirus disease-2019 (COVID-19) pandemic. Detection of neutralizing antibodies (NAbs) against the SARS-CoV-2 spike protein (S) confirms immunogenicity with...
Guardado en:
Autores principales: | Maaz Jalil DO, Marija Rowane OMS, Jayanth Rajan OMS, Robert Hostoffer DO, LhD, MSMEd, MBA, FACOP, FAAP, FACOI, FCCP |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4243f672b7ef4321b6b66bcfbbf04083 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Considerations for the Use of Biologic Agents in Patients With Chronic Rhinosinusitis With Nasal Polyposis
por: Do Hyun Kim, et al.
Publicado: (2021) -
Correction to: Impact of COVID-19 on vocal cord mobility: a case series study
por: Sameh M. Zamzam, et al.
Publicado: (2021) -
ALK-Positive Anaplastic Large Cell Lymphoma: A Diagnostic Dilemma for the Otolaryngologist in a Resource Poor Setting
por: Nicholas Figaro, et al.
Publicado: (2021) -
A rare case of primary mucosal melanoma involving the oropharynx
por: Anne Sophie Bonte, et al.
Publicado: (2021) -
Diffuse large B-cell lymphoma of the pterygopalatine fossa with multiple cranial nerve palsies
por: Shota Ida, et al.
Publicado: (2021)